Expression of the chemokine receptor CCR5 in psoriasis and results of a randomized placebo controlled trial with a CCR5 inhibitor

Several reports have indicated that the chemokine receptor CCR5 and its ligands, especially CCL5 (formerly known as RANTES), may play a role in the pathogenesis of psoriasis. The purpose of this investigation was to examine the expression of CCR5 and its ligands in chronic plaque psoriasis and to ev...

Descripción completa

Detalles Bibliográficos
Autores principales: de Groot, Marjan, Teunissen, Marcel B. M., Ortonne, Jean P., Lambert, Julien R., Naeyaert, Jean M., Picavet, Daisy I., Arreaza, M. Gladys, Simon, Jason S., Kraan, Maarten, Bos, Jan D., de Rie, Menno A.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2007
Materias:
Hot Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1950346/
https://www.ncbi.nlm.nih.gov/pubmed/17647003
http://dx.doi.org/10.1007/s00403-007-0764-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1950346/
https://www.ncbi.nlm.nih.gov/pubmed/17647003
http://dx.doi.org/10.1007/s00403-007-0764-7

Ejemplares similares